The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Winship 4851-19: A pilot study of neoadjuvant and adjuvant cemiplimab for high-risk cutaneous squamous cell carcinoma.
 
Michael C. Lowe
Research Funding - Bristol-Myers Squibb; Delcath Systems (Inst); Vaccinex (Inst)
 
Melinda Lynne Yushak
No Relationships to Disclose
 
Keith A. Delman
No Relationships to Disclose
 
Monica Rizzo
No Relationships to Disclose
 
Caroline Claar
No Relationships to Disclose
 
Allyson Schmidt
No Relationships to Disclose
 
Jeffrey M. Switchenko
No Relationships to Disclose
 
David H. Lawson
No Relationships to Disclose
 
Ragini Reiney Kudchadkar
Honoraria - Array BioPharma; Bristol-Myers Squibb
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Immunocore; Merck; Novartis; Regeneron
Research Funding - Merck (Inst); Regeneron (Inst)